Synairgen plc

Synairgen plc

SYGGF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$20.18K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Synairgen plcSynairgen plc-0.2--242%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$20,182.00
Enterprise Value$-4,533,818.00
Earnings per Share$-0.01
Beta7.41
Outstanding Shares201,817,000

Return

Return on Equity-242.42%ROE
Return on Assets-194.57%
Return on Invested Capital-253.01%

Valuation & Multiples

P/E Ratio-0.23P/E Ratio
PEG7.43PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.28
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 24, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 3, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Synairgen plc

34 employees
CEO: Joseph Tregonning Colliver

Synairgen plc is a biopharmaceutical company focused on the discovery and advancement of therapeutic drugs for various respiratory conditions. Their product pipeline features SNG001, an inhaled interferon beta under development for the t...